Denali Therapeutics, Inc. (DNLI)
16.88
+0.07
(+0.42%)
USD |
NASDAQ |
Dec 18, 15:49
Denali Therapeutics Accounts Payable (Quarterly): 6.745M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Novavax, Inc. | 15.23M |
| Agenus, Inc. | 85.29M |
| AIM ImmunoTech, Inc. | 1.252M |
| Protalix Biotherapeutics, Inc. | 5.375M |
| Armata Pharmaceuticals, Inc. | 1.28M |